Free Trial
→ The end may be near for these iconic stocks (From Chaikin Analytics) (Ad)tc pixel Free IBEX Stock Alerts

IBEX (IBEX) Financials

IBEX logo
$45.91 +1.16 (+2.59%)
Closing price 04:00 PM Eastern
Extended Trading
$46.00 +0.09 (+0.19%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for IBEX

Annual Income Statements for IBEX

This table shows IBEX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -16 11 7.77 13 21 32 34 37 46
Consolidated Net Income / (Loss)		 -16 11 7.77 13 21 32 34 37 46
Net Income / (Loss) Continuing Operations		 -21 -4.52 7.77 13 21 32 34 37 46
Total Pre-Tax Income 		-21 -0.90 10 15 19 40 41 46 54
Total Operating Income		 -18 6.44 23 17 21 40 39 47 55
Total Gross Profit		 81 110 129 443 493 148 152 558 644
Total Revenue		 342 368 405 443 493 523 509 558 644
Operating Revenue		 342 368 405 443 493 523 509 558 644
Total Cost of Revenue		 261 259 277 0.00 0.00 375 357 0.00 0.00
Total Operating Expenses		 99 103 106 426 472 108 113 512 589
Selling, General & Admin Expense		 - 28 17 77 80 89 93 109 113
Depreciation Expense		 12 21 24 14 18 19 19 17 20
Other Operating Expenses / (Income)		 86 54 64 335 374 - - 386 456
Total Other Income / (Expense), net		 -3.09 -7.35 -13 -1.89 -1.25 -0.15 1.56 -0.68 -0.67
Interest Expense		 - - - 1.89 1.29 0.79 0.51 1.63 0.94
Interest & Investment Income		 - - - - 0.04 0.64 2.07 0.96 0.27
Income Tax Expense		 -0.11 3.62 2.32 2.06 -2.08 8.74 7.33 9.07 7.96
Basic Earnings per Share		 - $0.00 - $0.74 $1.18 $1.74 $1.90 $2.51 $3.45
Weighted Average Basic Shares Outstanding		 - - 13.05M 17.65M 18.23M 18.20M 17.70M 14.68M 13.41M
Diluted Earnings per Share		 - ($0.36) - $0.71 $1.15 $1.67 $1.84 $2.36 $3.13
Weighted Average Diluted Shares Outstanding		 - - 13.05M 18.36M 18.72M 18.89M 18.26M 15.73M 14.81M
Weighted Average Basic & Diluted Shares Outstanding		 - - 13.05M 18.40M 18.25M 18.30M 16.80M 13.32M 13.28M

Quarterly Income Statements for IBEX

This table shows IBEX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 6.08 10 9.85 7.53 9.27 10 9.60 12 12 13 8.75
Consolidated Net Income / (Loss)		 6.08 10 9.85 7.53 9.27 10 9.60 12 12 13 8.75
Net Income / (Loss) Continuing Operations		 6.08 10 9.85 7.53 9.27 10 9.60 12 12 13 8.75
Total Pre-Tax Income 		7.35 12 13 9.51 12 13 12 14 15 16 9.72
Total Operating Income		 6.95 11 13 9.09 12 13 12 14 15 16 9.82
Total Gross Profit		 37 127 307 130 141 141 -239 151 48 164 281
Total Revenue		 133 127 125 130 141 141 147 151 164 164 164
Operating Revenue		 133 127 125 130 141 141 147 151 164 164 164
Total Cost of Revenue		 96 0.00 -183 0.00 0.00 0.00 386 0.00 117 0.00 -117
Total Operating Expenses		 30 116 295 121 129 127 -251 137 32 148 271
Selling, General & Admin Expense		 25 24 22 26 26 27 30 27 28 27 31
Depreciation Expense		 4.95 4.87 4.61 4.37 4.29 4.33 4.25 4.38 4.75 5.17 5.62
Total Other Income / (Expense), net		 0.40 0.31 0.37 0.42 -0.31 -0.37 -0.42 -0.19 -0.19 -0.19 -0.11
Interest Expense		 0.11 0.12 0.18 0.16 0.62 0.40 0.45 0.22 0.25 0.25 0.22
Interest & Investment Income		 0.51 0.43 0.54 0.58 0.31 0.03 0.03 0.03 0.06 0.06 0.12
Income Tax Expense		 1.27 1.28 3.39 1.98 2.35 2.49 2.25 1.47 2.88 2.64 0.97
Basic Earnings per Share		 $0.34 $0.59 $0.56 $0.45 $0.61 $0.79 $0.66 $0.90 $0.91 $0.99 $0.65
Weighted Average Basic Shares Outstanding		 17.89M 17.47M 17.70M 16.88M 15.13M 13.26M 14.68M 13.36M 13.47M 13.45M 13.41M
Diluted Earnings per Share		 $0.33 $0.57 $0.55 $0.43 $0.57 $0.73 $0.63 $0.82 $0.83 $0.89 $0.59
Weighted Average Diluted Shares Outstanding		 18.44M 18.04M 18.26M 17.49M 16.46M 14.40M 15.73M 14.61M 14.74M 14.99M 14.81M
Weighted Average Basic & Diluted Shares Outstanding		 17.57M 17.21M 16.80M 16.76M 13.19M 13.37M 13.32M 13.47M 13.41M 13.39M 13.28M

Annual Cash Flow Statements for IBEX

This table details how cash moves in and out of IBEX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents		 -8.42 -4.24 9.64 36 -9.01 8.60 5.29 -47 17
Net Cash From Operating Activities		 -5.75 2.20 52 16 40 42 36 46 59
Net Cash From Continuing Operating Activities		 -6.37 3.20 50 16 40 42 36 46 59
Net Income / (Loss) Continuing Operations		 -16 19 10 13 21 32 34 37 46
Consolidated Net Income / (Loss)		 -16 19 10 13 21 32 34 37 46
Depreciation Expense		 12 22 24 14 18 19 19 17 20
Amortization Expense		 0.00 0.64 0.71 - - - - - 14
Non-Cash Adjustments To Reconcile Net Income		 7.41 5.56 0.52 18 17 20 20 21 9.17
Changes in Operating Assets and Liabilities, net		 -10 -44 15 -29 -16 -29 -37 -29 -30
Net Cash From Investing Activities		 -5.44 -9.08 -4.84 -21 -26 -19 -8.86 -18 -28
Net Cash From Continuing Investing Activities		 -5.44 -9.08 -4.84 -21 -26 -19 -8.86 -18 -28
Purchase of Property, Plant & Equipment		 -5.19 -5.61 -4.28 -21 -26 -19 -8.86 -18 -28
Net Cash From Financing Activities		 3.19 2.55 -34 41 -22 -14 -22 -75 -14
Net Cash From Continuing Financing Activities		 3.19 2.55 -34 41 -22 -14 -22 -75 -14
Repayment of Debt		 -218 -185 -150 -128 -106 -58 -0.29 -83 -39
Repurchase of Common Equity		 - 0.00 0.00 -1.07 -3.41 -0.28 -22 -78 -14
Issuance of Debt		 224 205 129 118 88 43 0.24 83 39
Other Financing Activities, net		 -3.16 -17 -12 -6.99 -0.78 1.61 -0.12 3.35 0.46
Effect of Exchange Rate Changes		 0.20 -0.32 -0.02 -0.18 -0.97 -0.61 -0.02 -0.00 -0.05
Cash Interest Paid		 - - - 1.89 1.25 0.15 0.51 1.63 0.94
Cash Income Taxes Paid		 - - - 5.67 2.16 4.28 7.69 12 12

Quarterly Cash Flow Statements for IBEX

This table details how cash moves in and out of IBEX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -13 1.65 12 -0.42 -42 -7.23 2.37 7.34 -7.23 -0.05 17
Net Cash From Operating Activities		 -1.64 11 17 7.76 1.14 8.83 28 16 6.64 12 25
Net Cash From Continuing Operating Activities		 -1.64 11 17 7.76 1.14 8.83 28 16 6.64 12 25
Net Income / (Loss) Continuing Operations		 6.08 10 9.85 7.53 9.27 10 9.60 12 12 13 8.75
Consolidated Net Income / (Loss)		 6.08 10 9.85 7.53 9.27 10 9.60 12 12 13 8.75
Depreciation Expense		 4.95 4.87 4.61 4.37 4.29 4.33 4.25 4.38 4.75 5.17 5.62
Non-Cash Adjustments To Reconcile Net Income		 5.03 5.46 4.86 4.08 4.56 5.32 6.80 6.04 4.78 4.27 -5.91
Changes in Operating Assets and Liabilities, net		 -18 -9.21 -1.89 -8.22 -17 -11 7.29 -6.79 -15 -11 2.46
Net Cash From Investing Activities		 -2.89 -1.69 -2.22 -3.63 -4.32 -5.27 -5.16 -7.64 -12 -5.27 -3.16
Net Cash From Continuing Investing Activities		 -2.89 -1.69 -2.22 -3.63 -4.32 -5.27 -5.16 -7.64 -12 -5.27 -3.16
Purchase of Property, Plant & Equipment		 -2.89 -1.69 -2.22 -3.63 -4.32 -5.27 -5.16 -7.64 -12 -5.27 -3.16
Net Cash From Financing Activities		 -8.55 -8.06 -3.15 -4.60 -39 -11 -20 -0.65 -2.15 -6.66 -4.47
Net Cash From Continuing Financing Activities		 -8.55 -8.06 -3.15 -4.60 -39 -11 -20 -0.65 -2.15 -6.66 -4.47
Repayment of Debt		 -0.06 -0.06 -0.09 -0.06 -1.60 -49 -33 0.00 -11 -25 -3.00
Repurchase of Common Equity		 -8.44 -8.28 -3.01 -4.81 -47 -25 -1.59 -2.77 -2.79 -4.58 -4.25
Issuance of Debt		 0.06 0.06 0.09 0.06 9.10 60 13 0.00 11 25 3.00
Other Financing Activities, net		 -0.11 0.21 -0.14 0.21 0.16 2.52 0.46 2.12 0.64 -2.08 -0.22
Effect of Exchange Rate Changes		 0.07 -0.03 0.00 0.05 -0.02 0.14 -0.17 -0.04 0.00 0.02 -0.03
Cash Interest Paid		 0.11 0.12 0.18 0.16 0.62 0.40 0.45 0.22 0.25 0.25 0.22
Cash Income Taxes Paid		 2.93 1.41 2.26 3.38 3.40 3.11 2.06 3.53 3.58 0.49 3.99

Annual Balance Sheets for IBEX

This table presents IBEX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets		 188 195 274 294 293 294 273 309
Total Current Assets		 82 86 141 142 159 180 146 180
Cash & Equivalents		 8.87 22 58 49 57 63 15 33
Accounts Receivable		 73 64 83 75 86 99 117 125
Prepaid Expenses		 - - - 7.14 6.62 7.71 9.44 15
Current Deferred & Refundable Income Taxes		 - - - 6.39 5.97 9.08 1.52 4.23
Other Current Assets		 - - - 4.56 2.19 1.89 2.13 2.35
Plant, Property, & Equipment, net		 82 85 31 42 0.00 30 33 41
Total Noncurrent Assets		 21 22 101 110 135 84 95 89
Goodwill		 12 12 12 12 12 12 12 12
Noncurrent Deferred & Refundable Income Taxes		 2.52 2.22 4.25 9.28 4.59 4.29 7.16 7.17
Other Noncurrent Operating Assets		 3.40 4.83 81 89 118 68 76 70
Total Liabilities & Shareholders' Equity		 188 195 274 294 293 294 273 309
Total Liabilities		 180 179 194 181 143 128 139 139
Total Current Liabilities		 111 106 106 98 73 71 80 86
Short-Term Debt		 42 27 27 15 0.41 0.66 0.82 0.88
Accounts Payable		 47 53 55 21 19 17 19 23
Current Deferred Revenue		 - - - 8.60 6.41 4.75 5.50 6.38
Current Deferred & Payable Income Tax Liabilities		 1.47 3.09 3.66 2.97 3.02 6.08 1.99 0.43
Current Employee Benefit Liabilities		 - - - 33 29 31 39 41
Other Current Liabilities		 11 22 20 16 15 12 14 14
Total Noncurrent Liabilities		 68 73 88 83 70 57 59 53
Long-Term Debt		 7.18 3.78 1.80 0.66 0.60 0.87 0.80 0.78
Noncurrent Deferred Revenue		 - - - 3.99 1.38 1.13 1.13 2.08
Other Noncurrent Operating Liabilities		 2.36 7.49 14 78 68 55 57 51
Commitments & Contingencies		 - - - 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 8.63 16 81 113 150 166 134 170
Total Preferred & Common Equity		 8.63 16 81 113 150 166 134 170
Total Common Equity		 8.63 16 81 113 150 166 134 170
Common Stock		 96 96 158 198 205 210 218 227
Retained Earnings		 -117 -110 -111 -76 -45 -11 26 72
Treasury Stock		 - - - -3.41 -3.68 -25 -103 -118
Accumulated Other Comprehensive Income / (Loss)		 - - - -4.56 -6.31 -7.91 -6.34 -11

Quarterly Balance Sheets for IBEX

This table presents IBEX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 295 298 290 306 272 275 284 296 297
Total Current Assets		 168 169 171 189 159 149 153 159 165
Cash & Equivalents		 62 49 51 62 20 13 23 15 15
Accounts Receivable		 90 105 103 106 121 120 116 131 129
Prepaid Expenses		 6.84 5.28 5.89 8.20 6.91 8.10 10 9.17 17
Current Deferred & Refundable Income Taxes		 6.20 8.37 9.13 10 8.97 4.98 1.51 1.45 2.06
Other Current Assets		 2.23 1.96 2.19 1.57 2.04 2.52 2.03 1.94 1.92
Plant, Property, & Equipment, net		 38 36 31 0.00 0.00 0.00 37 44 43
Total Noncurrent Assets		 90 93 87 118 113 126 95 93 89
Goodwill		 12 12 12 12 12 12 12 12 12
Noncurrent Deferred & Refundable Income Taxes		 4.34 4.29 4.00 4.41 5.05 5.99 8.23 8.60 7.95
Other Noncurrent Operating Assets		 74 77 71 101 97 108 75 73 69
Total Liabilities & Shareholders' Equity		 295 298 290 306 272 275 284 296 297
Total Liabilities		 139 142 130 135 164 151 140 141 136
Total Current Liabilities		 74 74 71 78 111 89 84 87 85
Short-Term Debt		 0.40 0.44 0.59 0.70 33 20 0.85 0.84 0.82
Accounts Payable		 18 18 18 20 20 18 25 25 21
Current Deferred Revenue		 5.92 6.46 5.40 4.87 7.22 6.02 6.16 8.52 6.83
Current Deferred & Payable Income Tax Liabilities		 3.16 3.35 3.32 5.89 4.64 0.82 1.24 0.75 2.89
Current Employee Benefit Liabilities		 33 32 31 34 33 30 36 37 38
Other Current Liabilities		 13 14 13 12 12 14 14 14 15
Total Noncurrent Liabilities		 66 68 60 57 53 62 56 55 52
Long-Term Debt		 0.58 0.56 0.82 0.80 0.70 0.74 0.73 0.59 0.57
Noncurrent Deferred Revenue		 1.50 1.63 1.30 1.08 1.12 1.06 1.08 1.47 1.83
Other Noncurrent Operating Liabilities		 64 66 57 56 51 60 54 53 49
Total Equity & Noncontrolling Interests		 156 156 159 171 109 124 144 155 161
Total Preferred & Common Equity		 156 156 159 171 109 124 144 155 161
Total Common Equity		 156 156 159 171 109 124 144 155 161
Common Stock		 206 208 209 211 212 216 222 224 224
Retained Earnings		 -37 -31 -21 -3.59 5.68 16 38 50 63
Treasury Stock		 -5.73 -14 -22 -30 -102 -102 -106 -109 -113
Accumulated Other Comprehensive Income / (Loss)		 -7.21 -6.13 -6.55 -6.15 -7.25 -6.49 -9.74 -11 -13

Annual Metrics And Ratios for IBEX

This table displays calculated financial ratios and metrics derived from IBEX's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding		 - - - - - - - 13,372,404.00 13,389,116.00
DEI Adjusted Shares Outstanding		 - - - - - - - 13,372,404.00 13,389,116.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - 2.76 3.46
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 7.65% 9.98% 9.44% 11.16% 6.14% -2.78% 9.77% 15.37%
EBITDA Growth		 0.00% 354.93% 63.67% -11.62% 24.27% 53.55% -0.96% 8.41% 39.09%
EBIT Growth		 0.00% 95.67% 1,215.60% 69.01% 21.00% 96.26% -2.59% 18.22% 17.92%
NOPAT Growth		 0.00% 136.23% 287.06% -15.63% 55.10% 38.82% 2.13% 15.54% 25.38%
Net Income Growth		 0.00% 169.04% -29.14% 68.46% 63.92% 47.19% 6.56% 9.54% 25.68%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 61.97% 45.22% 10.18% 28.26% 32.63%
Operating Cash Flow Growth		 0.00% 138.32% 2,248.73% -68.91% 148.84% 4.63% -14.24% 27.21% 29.20%
Free Cash Flow Firm Growth		 0.00% 0.00% 143.00% -145.47% 394.56% -70.75% 15.10% 0.56% 31.35%
Invested Capital Growth		 0.00% 0.00% -26.06% 42.80% -33.50% 16.40% 11.82% 15.27% 15.55%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02% 4.22% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.52% -1.49% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 13.09% -1.29% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 18.26% 1.03% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 18.84% -0.67% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 20.26% 3.51% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.04% 29.91% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 40.30% 288.17%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -4.95% -8.52% -5.07%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 23.64% 29.78% 31.72% 100.00% 100.00% 100.00% 100.00% 30.91% 100.00%
EBITDA Margin		 -2.47% 5.85% 8.70% 7.03% 7.86% 11.37% 11.58% 11.44% 13.79%
Operating Margin		 -5.19% 1.75% 5.59% 3.84% 4.18% 7.74% 7.75% 8.35% 8.53%
EBIT Margin		 -6.10% -0.25% 2.49% 3.84% 4.18% 7.74% 7.75% 8.35% 8.53%
Profit (Net Income) Margin		 -4.64% 2.98% 1.92% 2.95% 4.35% 6.04% 6.62% 6.60% 7.19%
Tax Burden Percent		 76.09% -1,212.94% 77.05% 86.38% 110.72% 78.32% 82.11% 80.26% 85.33%
Interest Burden Percent		 100.00% 100.00% 100.00% 88.90% 93.96% 99.62% 103.95% 98.54% 98.78%
Effective Tax Rate		 0.00% 0.00% 22.95% 13.62% -10.72% 21.68% 17.89% 19.74% 14.67%
Return on Invested Capital (ROIC)		 0.00% 7.88% 17.53% 14.33% 22.70% 36.46% 32.68% 33.23% 36.09%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 20.08% 6.42% 11.32% -16.10% 36.72% 30.50% 34.68% 38.65%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 246.29% 45.19% 12.71% -0.59% -12.48% -11.36% -8.66% -5.67%
Return on Equity (ROE)		 0.00% 254.17% 62.72% 27.04% 22.11% 23.98% 21.32% 24.57% 30.43%
Cash Return on Invested Capital (CROIC)		 0.00% -192.12% 47.49% -20.92% 62.94% 21.30% 21.52% 19.04% 21.67%
Operating Return on Assets (OROA)		 0.00% -0.48% 5.26% 7.26% 7.26% 13.78% 13.43% 16.44% 18.88%
Return on Assets (ROA)		 0.00% 5.82% 4.05% 5.58% 7.55% 10.75% 11.46% 13.00% 15.91%
Return on Common Equity (ROCE)		 0.00% 254.17% 62.72% 27.04% 22.11% 23.98% 21.32% 24.57% 30.43%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 127.09% 48.12% 16.23% 18.91% 21.06% 20.30% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -12 4.51 17 15 23 32 32 37 47
NOPAT Margin		 -3.64% 1.22% 4.31% 3.32% 4.63% 6.06% 6.37% 6.70% 7.28%
Net Nonoperating Expense Percent (NNEP)		 0.00% -12.20% 11.11% 3.01% 38.80% -0.27% 2.17% -1.45% -2.56%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 27.52% 27.29%
Cost of Revenue to Revenue		 76.36% 70.22% 68.28% 0.00% 0.00% 0.00% 0.00% 69.09% 0.00%
SG&A Expenses to Revenue		 0.00% 7.57% 4.28% 17.36% 16.26% 16.95% 18.31% 19.48% 17.55%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 28.83% 28.03% 26.13% 96.16% 95.82% 92.26% 92.25% 22.56% 91.47%
Earnings before Interest and Taxes (EBIT)		 -21 -0.90 10 17 21 40 39 47 55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -8.45 22 35 31 39 59 59 64 89
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 10.49 5.60 3.16 2.74 2.58 1.68 2.90 2.39
Price to Tangible Book Value (P/TBV)		 0.00 0.00 58.94 3.88 3.05 2.80 1.81 3.18 2.57
Price to Revenue (P/Rev)		 0.26 0.25 0.22 0.57 0.63 0.74 0.55 0.70 0.63
Price to Earnings (P/E)		 0.00 8.25 11.64 19.46 14.47 12.27 8.28 10.56 8.78
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 12.12% 8.59% 5.14% 6.91% 8.15% 12.08% 9.47% 11.39%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1.65 1.91 2.46 3.45 3.54 2.08 3.11 2.70
Enterprise Value to Revenue (EV/Rev)		 0.00 0.51 0.40 0.67 0.56 0.63 0.43 0.67 0.58
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 8.77 4.58 9.53 7.16 5.57 3.69 5.88 4.23
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 16.02 17.42 13.44 8.18 5.51 8.05 6.84
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 41.92 9.26 20.17 12.14 10.44 6.71 10.04 8.01
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 85.83 3.12 18.47 6.93 7.91 6.05 8.22 6.37
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 3.42 0.00 4.38 17.87 10.19 17.51 13.34
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 0.00 12.47 5.78 1.24 0.14 0.01 0.01 0.01 0.01
Long-Term Debt to Equity		 0.00 7.62 4.08 0.91 0.01 0.00 0.01 0.01 0.00
Financial Leverage		 0.00 12.27 7.04 1.12 0.04 -0.34 -0.37 -0.25 -0.15
Leverage Ratio		 0.00 21.82 15.48 4.85 2.93 2.23 1.86 1.89 1.91
Compound Leverage Factor		 0.00 21.82 15.48 4.31 2.75 2.22 1.93 1.86 1.89
Debt to Total Capital		 0.00% 92.58% 85.25% 55.45% 12.18% 0.67% 0.91% 1.19% 0.97%
Short-Term Debt to Total Capital		 0.00% 35.99% 25.10% 14.76% 11.67% 0.27% 0.39% 0.61% 0.51%
Long-Term Debt to Total Capital		 0.00% 56.59% 60.14% 40.69% 0.51% 0.40% 0.52% 0.59% 0.45%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 7.42% 14.75% 44.55% 87.82% 99.33% 99.09% 98.81% 99.03%
Debt to EBITDA		 0.00 5.00 2.65 3.22 0.41 0.02 0.03 0.03 0.02
Net Debt to EBITDA		 0.00 4.57 2.02 1.36 -0.85 -0.95 -1.04 -0.22 -0.35
Long-Term Debt to EBITDA		 0.00 3.05 1.87 2.36 0.02 0.01 0.01 0.01 0.01
Debt to NOPAT		 0.00 23.87 5.35 6.82 0.69 0.03 0.05 0.04 0.04
Net Debt to NOPAT		 0.00 21.85 4.07 2.87 -1.45 -1.78 -1.89 -0.37 -0.66
Long-Term Debt to NOPAT		 0.00 14.59 3.77 5.00 0.03 0.02 0.03 0.02 0.02
Altman Z-Score		 0.00 1.18 1.64 2.20 2.76 4.00 3.87 4.71 5.12
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 0.00 0.73 0.81 1.34 1.46 2.17 2.53 1.82 2.10
Quick Ratio		 0.00 0.73 0.81 1.33 1.27 1.96 2.27 1.66 1.85
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -110 47 -21 63 19 21 21 28
Operating Cash Flow to CapEx		 -110.65% 39.24% 1,207.54% 77.21% 154.35% 220.87% 405.42% 248.53% 212.18%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 -11.36 49.13 23.39 41.48 13.12 30.08
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 8.50 31.04 52.85 69.84 27.95 63.04
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 -2.51 10.93 28.92 52.62 16.70 33.33
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 1.96 2.11 1.89 1.73 1.78 1.73 1.97 2.21
Accounts Receivable Turnover		 0.00 5.05 5.91 6.03 6.23 6.46 5.50 5.18 5.31
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 4.48 4.85 7.68 13.55 0.00 0.00 17.89 17.58
Accounts Payable Turnover		 0.00 5.52 5.53 0.00 0.00 0.00 0.00 21.78 0.00
Days Sales Outstanding (DSO)		 0.00 72.23 61.74 60.52 58.61 56.46 66.37 70.52 68.70
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 66.16 66.04 0.00 0.00 0.00 0.00 16.76 0.00
Cash Conversion Cycle (CCC)		 0.00 6.07 -4.30 60.52 58.61 56.46 66.37 53.77 68.70
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 0.00 114 85 121 80 94 105 121 139
Invested Capital Turnover		 0.00 6.44 4.07 4.32 4.90 6.02 5.13 4.96 4.96
Increase / (Decrease) in Invested Capital		 0.00 114 -30 36 -40 13 11 16 19
Enterprise Value (EV)		 0.00 189 162 297 277 331 217 375 376
Market Capitalization		 90 90 90 255 310 387 279 389 407
Book Value per Share		 $0.00 $1.81 $1.24 $6.18 $6.17 $8.22 $9.63 $10.04 $12.71
Tangible Book Value per Share		 $0.00 ($1.29) $0.12 $5.03 $5.52 $7.57 $8.94 $9.16 $11.83
Total Capital		 0.00 116 109 181 129 151 167 136 172
Total Debt		 0.00 108 93 100 16 1.01 1.53 1.62 1.66
Total Long-Term Debt		 0.00 66 66 74 0.66 0.60 0.87 0.80 0.78
Net Debt		 0.00 99 71 42 -33 -56 -61 -14 -31
Capital Expenditures (CapEx)		 5.19 5.61 4.28 21 26 19 8.86 18 28
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 3.36 -14 4.53 11 28 47 51 62
Debt-free Net Working Capital (DFNWC)		 0.00 12 7.86 62 60 86 110 67 95
Net Working Capital (NWC)		 0.00 -30 -20 36 45 85 109 66 94
Net Nonoperating Expense (NNE)		 3.44 -6.46 9.68 1.63 1.38 0.12 -1.28 0.54 0.57
Net Nonoperating Obligations (NNO)		 0.00 106 68 40 -33 -56 -61 -14 -31
Total Depreciation and Amortization (D&A)		 12 22 25 14 18 19 19 17 34
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.91% -3.46% 1.02% 2.20% 5.42% 9.22% 9.16% 9.69%
Debt-free Net Working Capital to Revenue		 0.00% 3.32% 1.94% 14.07% 12.10% 16.39% 21.56% 11.91% 14.75%
Net Working Capital to Revenue		 0.00% -8.04% -4.84% 8.04% 9.04% 16.31% 21.43% 11.76% 14.61%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.16 $0.00 $1.74 $1.90 $2.51 $3.45
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 13.05M 18.40M 18.25M 18.20M 17.70M 14.68M 13.41M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.15 $0.00 $1.67 $1.84 $2.36 $3.13
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 13.05M 18.40M 18.25M 18.89M 18.26M 15.73M 14.81M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 13.05M 18.40M 18.25M 18.30M 16.80M 13.32M 13.28M
Normalized Net Operating Profit after Tax (NOPAT)		 -12 4.51 17 15 14 32 32 37 47
Normalized NOPAT Margin		 -3.64% 1.22% 4.31% 3.32% 2.93% 6.06% 6.37% 6.70% 7.28%
Pre Tax Income Margin		 -6.10% -0.25% 2.49% 3.42% 3.93% 7.71% 8.06% 8.23% 8.43%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 9.01 16.00 51.11 76.71 28.53 58.72
NOPAT to Interest Expense		 0.00 0.00 0.00 7.78 17.72 40.03 62.99 22.89 50.11
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 -2.00 -4.11 27.18 59.48 17.28 29.01
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 -3.22 -2.39 16.10 45.76 11.65 20.40
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 -0.92% 14.59% 1.56% 30.56% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.92% 14.59% 1.56% 38.77% 15.87% 0.87% 64.05% 211.63% 31.04%

Quarterly Metrics And Ratios for IBEX

This table displays calculated financial ratios and metrics derived from IBEX's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - 13,191,924.00 13,372,404.00 13,372,404.00 - 13,405,520.00 13,389,116.00
DEI Adjusted Shares Outstanding		 - - - - - 13,191,924.00 13,372,404.00 13,372,404.00 - 13,405,520.00 13,389,116.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - 0.79 0.72 0.90 - 0.99 0.65
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -4.80% -3.62% 0.08% 4.10% 6.07% 10.99% 18.15% 16.55% 16.73% 16.82% 11.64%
EBITDA Growth		 -25.82% -8.90% 30.84% 0.66% 36.33% 9.36% -5.53% 34.29% 23.58% 20.77% -6.44%
EBIT Growth		 -39.33% -13.55% 54.94% 9.13% 71.70% 18.14% -4.72% 50.67% 28.16% 21.21% -19.90%
NOPAT Growth		 -38.92% -10.33% 112.50% 2.55% 65.66% 7.30% 3.80% 69.62% 30.01% 25.18% -10.99%
Net Income Growth		 -34.47% -8.59% 118.29% 1.43% 52.56% 1.54% -2.53% 59.90% 31.82% 27.28% -8.85%
EPS Growth		 -32.65% -3.39% 129.17% 10.26% 72.73% 28.07% 14.55% 90.70% 45.61% 21.92% -6.35%
Operating Cash Flow Growth		 -130.93% -15.76% -0.07% -10.62% 169.70% -22.77% 60.35% 101.88% 482.30% 34.39% -11.15%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 90.79% 95.09% 89.02% -306.23% 99.88% -8.80% 86.49% -64.03%
Invested Capital Growth		 0.00% 0.00% 11.82% 16.11% 13.46% 19.76% 15.27% 11.08% 14.55% 11.35% 15.55%
Revenue Q/Q Growth		 6.44% -4.40% -1.79% 4.16% 8.45% 0.04% 4.55% 0.00% 8.63% 0.11% -0.08%
EBITDA Q/Q Growth		 -11.07% 35.77% 8.24% -22.98% 20.45% 8.91% -6.50% 0.00% 10.84% 6.43% -27.57%
EBIT Q/Q Growth		 -16.61% 62.40% 14.07% -29.35% 31.19% 11.75% -8.01% 0.00% 11.59% 5.68% -39.21%
NOPAT Q/Q Growth		 -18.17% 74.75% -4.63% -24.80% 32.19% 13.19% -7.74% 0.00% 1.32% 8.98% -34.40%
Net Income Q/Q Growth		 -18.18% 69.71% -4.51% -23.50% 23.06% 12.96% -8.34% 0.00% 1.45% 9.07% -34.36%
EPS Q/Q Growth		 -15.38% 72.73% -3.51% -21.82% 32.56% 28.07% -13.70% 0.00% 1.22% 7.23% -33.71%
Operating Cash Flow Q/Q Growth		 -118.85% 798.29% 52.41% -55.45% -85.30% 673.71% 216.46% 0.00% -57.60% 78.57% 109.23%
Free Cash Flow Firm Q/Q Growth		 -16.35% 2.29% 98.51% -445.18% 37.90% -118.28% 45.02% 0.00% -58,472.41% 72.90% -567.70%
Invested Capital Q/Q Growth		 13.80% 1.81% -4.95% 5.43% 11.20% 7.47% -8.52% 0.00% 14.68% 4.47% -5.07%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 27.71% 31.32% 246.92% 100.00% 100.00% 100.00% -162.13% 100.00% 28.98% 100.00% 171.00%
EBITDA Margin		 8.97% 12.73% 14.03% 10.38% 11.53% 12.55% 11.22% 11.96% 12.20% 12.97% 9.40%
Operating Margin		 5.24% 8.90% 10.33% 7.01% 8.48% 9.47% 8.33% 9.06% 9.31% 9.83% 5.98%
EBIT Margin		 5.24% 8.90% 10.33% 7.01% 8.48% 9.47% 8.33% 9.06% 9.31% 9.83% 5.98%
Profit (Net Income) Margin		 4.58% 8.13% 7.91% 5.81% 6.59% 7.44% 6.52% 7.97% 7.44% 8.10% 5.32%
Tax Burden Percent		 82.68% 88.96% 74.38% 79.17% 79.77% 80.80% 81.03% 89.12% 80.92% 83.44% 90.04%
Interest Burden Percent		 105.77% 102.72% 102.85% 104.63% 97.41% 97.21% 96.58% 98.63% 98.76% 98.84% 98.91%
Effective Tax Rate		 17.32% 11.04% 25.62% 20.83% 20.23% 19.20% 18.97% 10.88% 19.08% 16.56% 9.96%
Return on Invested Capital (ROIC)		 41.12% 73.15% 39.46% 27.77% 30.58% 33.90% 33.48% 0.00% 0.00% 0.00% 26.68%
ROIC Less NNEP Spread (ROIC-NNEP)		 39.74% 72.04% 38.99% 27.22% 32.02% 35.34% 34.39% 0.00% 0.00% 0.00% 27.11%
Return on Net Nonoperating Assets (RNNOA)		 -12.22% -22.27% -14.52% -10.14% -4.14% -5.19% -8.59% 0.00% 0.00% 0.00% -3.97%
Return on Equity (ROE)		 28.90% 50.87% 24.93% 17.63% 26.44% 28.71% 24.90% 0.00% 0.00% 0.00% 22.71%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 21.52% 16.81% 18.88% 12.64% 19.04% -10.50% -13.56% -10.74% 21.67%
Operating Return on Assets (OROA)		 9.02% 15.62% 17.90% 11.97% 15.50% 17.98% 16.41% 0.00% 0.00% 0.00% 13.23%
Return on Assets (ROA)		 7.88% 14.28% 13.69% 9.91% 12.05% 14.12% 12.84% 0.00% 0.00% 0.00% 11.78%
Return on Common Equity (ROCE)		 28.90% 50.87% 24.93% 17.63% 26.44% 28.71% 24.90% 0.00% 0.00% 0.00% 22.71%
Return on Equity Simple (ROE_SIMPLE)		 18.76% 17.78% 0.00% 19.73% 33.92% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 5.74 10 9.57 7.20 9.51 11 9.94 12 12 13 8.84
NOPAT Margin		 4.33% 7.92% 7.69% 5.55% 6.76% 7.65% 6.75% 8.08% 7.53% 8.20% 5.38%
Net Nonoperating Expense Percent (NNEP)		 1.38% 1.11% 0.46% 0.55% -1.44% -1.44% -0.91% -0.41% -94.70% -4.88% -0.43%
Return On Investment Capital (ROIC_SIMPLE)		 3.66% - - - 6.66% 7.44% 7.31% 8.41% 7.93% 8.31% 5.14%
Cost of Revenue to Revenue		 72.29% 68.68% -146.92% 0.00% 0.00% 0.00% 262.13% 0.00% 71.02% 0.00% -71.00%
SG&A Expenses to Revenue		 18.74% 18.59% 17.41% 20.21% 18.27% 19.23% 20.22% 17.55% 16.78% 16.71% 19.16%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 22.47% 22.42% 236.59% 92.99% 91.52% 90.53% -170.46% 90.94% 19.67% 90.17% 165.02%
Earnings before Interest and Taxes (EBIT)		 6.95 11 13 9.09 12 13 12 14 15 16 9.82
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 12 16 17 13 16 18 17 18 20 21 15
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.18 1.70 1.68 1.96 3.31 2.59 2.90 3.77 3.33 2.24 2.39
Price to Tangible Book Value (P/TBV)		 2.36 1.84 1.81 2.11 3.71 2.86 3.18 4.11 3.60 2.41 2.57
Price to Revenue (P/Rev)		 0.66 0.53 0.55 0.65 0.69 0.60 0.70 0.00 0.00 0.00 0.63
Price to Earnings (P/E)		 11.64 9.57 8.28 9.94 9.75 8.66 10.56 0.00 0.00 0.00 8.78
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 8.59% 10.44% 12.08% 10.06% 10.26% 11.55% 9.47% 0.00% 0.00% 0.00% 11.39%
Enterprise Value to Invested Capital (EV/IC)		 2.71 2.02 2.08 2.49 3.05 2.50 3.11 4.25 3.56 2.35 2.70
Enterprise Value to Revenue (EV/Rev)		 0.57 0.44 0.43 0.54 0.72 0.61 0.67 0.00 0.00 0.00 0.58
Enterprise Value to EBITDA (EV/EBITDA)		 5.20 4.05 3.69 4.66 5.91 5.07 5.88 0.00 0.00 0.00 4.23
Enterprise Value to EBIT (EV/EBIT)		 8.00 6.36 5.51 6.84 8.28 6.96 8.05 0.00 0.00 0.00 6.84
Enterprise Value to NOPAT (EV/NOPAT)		 10.27 8.10 6.71 8.45 10.30 8.88 10.04 0.00 0.00 0.00 8.01
Enterprise Value to Operating Cash Flow (EV/OCF)		 7.70 6.18 6.05 7.86 9.91 9.35 8.22 0.00 0.00 0.00 6.37
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 10.19 15.94 17.17 21.52 17.51 0.00 0.00 0.00 13.34
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.01 0.01 0.01 0.01 0.31 0.17 0.01 0.01 0.01 0.01 0.01
Long-Term Debt to Equity		 0.00 0.01 0.01 0.00 0.01 0.01 0.01 0.01 0.00 0.00 0.00
Financial Leverage		 -0.31 -0.31 -0.37 -0.37 -0.13 -0.15 -0.25 -0.26 0.00 -0.02 -0.15
Leverage Ratio		 1.91 1.82 1.86 1.84 2.15 1.99 1.89 1.88 2.16 2.01 1.91
Compound Leverage Factor		 2.02 1.87 1.91 1.92 2.10 1.94 1.83 1.85 2.13 1.98 1.89
Debt to Total Capital		 0.64% 0.87% 0.91% 0.87% 23.74% 14.23% 1.19% 1.08% 0.92% 0.86% 0.97%
Short-Term Debt to Total Capital		 0.28% 0.36% 0.39% 0.40% 23.25% 13.72% 0.61% 0.58% 0.54% 0.51% 0.51%
Long-Term Debt to Total Capital		 0.36% 0.51% 0.52% 0.46% 0.49% 0.51% 0.59% 0.50% 0.38% 0.35% 0.45%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 99.36% 99.13% 99.09% 99.13% 76.26% 85.77% 98.81% 98.92% 99.08% 99.14% 99.03%
Debt to EBITDA		 0.02 0.03 0.03 0.03 0.54 0.32 0.03 0.00 0.00 0.00 0.02
Net Debt to EBITDA		 -0.85 -0.90 -1.04 -1.03 0.22 0.12 -0.22 0.00 0.00 0.00 -0.35
Long-Term Debt to EBITDA		 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.01
Debt to NOPAT		 0.04 0.05 0.05 0.05 0.93 0.56 0.04 0.00 0.00 0.00 0.04
Net Debt to NOPAT		 -1.68 -1.80 -1.89 -1.87 0.38 0.21 -0.37 0.00 0.00 0.00 -0.66
Long-Term Debt to NOPAT		 0.02 0.03 0.03 0.02 0.02 0.02 0.02 0.00 0.00 0.00 0.02
Altman Z-Score		 3.47 3.45 3.57 3.68 3.62 3.73 4.29 2.95 2.88 2.38 4.64
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.28 2.42 2.53 2.42 1.44 1.67 1.82 1.82 1.83 1.95 2.10
Quick Ratio		 2.07 2.18 2.27 2.17 1.28 1.49 1.66 1.65 1.69 1.70 1.85
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -102 -100 -1.49 -8.10 -5.03 -11 -6.04 -0.01 -5.47 -1.48 -9.90
Operating Cash Flow to CapEx		 -56.60% 675.99% 784.77% 213.83% 26.42% 167.61% 541.52% 205.13% 56.63% 225.00% 784.79%
Free Cash Flow to Firm to Interest Expense		 -922.11 -806.57 -8.49 -50.01 -8.11 -27.18 -13.47 -0.04 -22.07 -5.96 -44.60
Operating Cash Flow to Interest Expense		 -14.75 92.19 99.55 47.91 1.84 21.85 62.36 72.21 26.79 47.65 111.82
Operating Cash Flow Less CapEx to Interest Expense		 -40.80 78.55 86.87 25.51 -5.13 8.81 50.84 37.01 -20.52 26.47 97.57
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.72 1.76 1.73 1.71 1.83 1.90 1.97 0.00 0.00 0.00 2.21
Accounts Receivable Turnover		 4.89 4.91 5.50 5.23 4.62 4.79 5.18 0.00 0.00 0.00 5.31
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 14.28 16.16 0.00 0.00 0.00 0.00 17.89 0.00 0.00 0.00 17.58
Accounts Payable Turnover		 10.26 31.81 0.00 0.00 0.00 0.00 21.78 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 74.59 74.28 66.37 69.82 78.98 76.17 70.52 0.00 0.00 0.00 68.70
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 35.56 11.47 0.00 0.00 0.00 0.00 16.76 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 39.03 62.81 66.37 69.82 78.98 76.17 53.77 0.00 0.00 0.00 68.70
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 108 110 105 110 123 132 121 123 140 147 139
Invested Capital Turnover		 9.50 9.24 5.13 5.00 4.52 4.43 4.96 0.00 0.00 0.00 4.96
Increase / (Decrease) in Invested Capital		 108 110 11 15 15 22 16 12 18 15 19
Enterprise Value (EV)		 293 222 217 275 374 329 375 521 500 346 376
Market Capitalization		 341 271 279 336 360 321 389 542 514 360 407
Book Value per Share		 $8.70 $9.07 $9.63 $10.18 $6.50 $9.41 $10.04 $10.75 $11.47 $11.99 $12.71
Tangible Book Value per Share		 $8.04 $8.39 $8.94 $9.48 $5.79 $8.52 $9.16 $9.86 $10.59 $11.11 $11.83
Total Capital		 157 161 167 173 143 145 136 145 156 162 172
Total Debt		 1.00 1.41 1.53 1.50 34 21 1.62 1.57 1.43 1.39 1.66
Total Long-Term Debt		 0.56 0.82 0.87 0.80 0.70 0.74 0.80 0.73 0.59 0.57 0.78
Net Debt		 -48 -49 -61 -61 14 7.62 -14 -21 -14 -14 -31
Capital Expenditures (CapEx)		 2.89 1.69 2.22 3.63 4.32 5.27 5.16 7.64 12 5.27 3.16
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 47 51 47 49 61 67 51 47 57 66 62
Debt-free Net Working Capital (DFNWC)		 96 101 110 111 82 80 67 70 73 81 95
Net Working Capital (NWC)		 95 101 109 111 48 60 66 69 72 81 94
Net Nonoperating Expense (NNE)		 -0.33 -0.27 -0.27 -0.33 0.25 0.30 0.34 0.17 0.15 0.16 0.10
Net Nonoperating Obligations (NNO)		 -48 -49 -61 -61 14 7.62 -14 -21 -14 -14 -31
Total Depreciation and Amortization (D&A)		 4.95 4.87 4.61 4.37 4.29 4.33 4.25 4.38 4.75 5.17 5.62
Debt-free, Cash-free Net Working Capital to Revenue		 9.10% 9.93% 9.22% 9.57% 11.77% 12.42% 9.16% 0.00% 0.00% 0.00% 9.69%
Debt-free Net Working Capital to Revenue		 18.65% 19.90% 21.56% 21.70% 15.64% 14.84% 11.91% 0.00% 0.00% 0.00% 14.75%
Net Working Capital to Revenue		 18.56% 19.78% 21.43% 21.56% 9.27% 11.14% 11.76% 0.00% 0.00% 0.00% 14.61%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.34 $0.59 $0.56 $0.45 $0.61 $0.79 $0.66 $0.90 $0.91 $0.99 $0.65
Adjusted Weighted Average Basic Shares Outstanding		 17.89M 17.47M 17.70M 16.88M 15.13M 13.26M 14.68M 13.36M 13.47M 13.45M 13.41M
Adjusted Diluted Earnings per Share		 $0.33 $0.57 $0.55 $0.43 $0.57 $0.73 $0.63 $0.82 $0.83 $0.89 $0.59
Adjusted Weighted Average Diluted Shares Outstanding		 18.44M 18.04M 18.26M 17.49M 16.46M 14.40M 15.73M 14.61M 14.74M 14.99M 14.81M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 17.57M 17.21M 16.80M 16.76M 13.19M 13.37M 13.32M 13.47M 13.41M 13.39M 13.28M
Normalized Net Operating Profit after Tax (NOPAT)		 5.74 10 9.57 7.20 9.51 11 9.94 12 12 13 8.84
Normalized NOPAT Margin		 4.33% 7.92% 7.69% 5.55% 6.76% 7.65% 6.75% 8.08% 7.53% 8.20% 5.38%
Pre Tax Income Margin		 5.54% 9.14% 10.63% 7.33% 8.26% 9.21% 8.05% 8.94% 9.19% 9.71% 5.91%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 62.59 90.98 73.54 56.12 19.24 32.99 27.37 63.13 61.64 64.88 44.24
NOPAT to Interest Expense		 51.74 80.94 54.70 44.43 15.35 26.66 22.18 56.26 49.88 54.14 39.83
EBIT Less CapEx to Interest Expense		 36.53 77.35 60.85 33.72 12.27 19.96 15.85 27.93 14.33 43.71 30.00
NOPAT Less CapEx to Interest Expense		 25.69 67.31 42.01 22.02 8.38 13.62 10.66 21.06 2.57 32.96 25.59
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 35.08% 65.50% 64.05% 72.66% 169.54% 214.01% 211.63% 0.00% 0.00% 0.00% 31.04%

Financials Breakdown Chart

Key Financial Trends

IBEX’s financial performance has generally improved over the past several years, although the latest quarter shows some margin pressure and unusual statement classifications. Revenue increased from $124.5 million in Q4 2024 to $147.1 million in Q4 2025 and $164.3 million in Q4 2026. The latest four quarters generated approximately $644.1 million of revenue, up about 15% from the comparable period a year earlier.

Profitability has also improved over the broader period. Net income rose from $4.5 million in Q4 2023 to $9.8 million in Q4 2024, although it slipped to $9.6 million in Q4 2025 and $8.7 million in Q4 2026. Across the latest four quarters, net income totaled approximately $53.8 million, compared with about $44.0 million in the prior four-quarter period. However, Q4 2026 net income declined sequentially from $13.3 million in Q3, while operating income fell from $16.2 million to $9.8 million.

Cash generation remains a key strength. Operating cash flow was positive in every reported quarter from Q1 2024 through Q4 2026, except for Q2 2024, and reached $24.8 million in Q4 2026. Based on the available quarterly figures, operating cash flow for the latest four quarters was approximately $59.0 million, well above the roughly $45.7 million generated in the comparable preceding period. Still, IBEX’s balance sheet shows cash of only $15.4 million at March 31, 2026, reflecting the impact of capital spending, share repurchases and other financing activity.

  • Revenue momentum remains strong: Quarterly revenue increased from $124.5 million in Q4 2024 to $164.3 million in Q4 2026, with revenue reaching approximately $164 million in both Q3 and Q4 2026.
  • Trailing operating cash flow has improved: Operating cash flow increased approximately 29% across the latest four-quarter period compared with the previous four quarters.
  • IBEX consistently produces net income: The company has remained profitable in every quarter provided, and latest-four-quarter net income was higher year over year despite weaker results in Q4 2026.
  • Depreciation is rising alongside investment: Quarterly depreciation increased from approximately $4.4 million in Q1 2026 to $5.6 million in Q4 2026, consistent with a larger asset base and continued investment in property and equipment.
  • Debt levels appear manageable: At March 31, 2026, short- and long-term debt totaled approximately $1.4 million, down substantially from the much higher debt balances reported in early 2025.
  • Share repurchases support per-share results: IBEX repurchased common equity in each reported 2026 cash flow statement. Weighted-average basic shares declined from 16.9 million in Q1 2025 to approximately 13.4 million in Q3 2026, helping support earnings per share.
  • Liquidity is adequate but increasingly dependent on collections: At March 31, 2026, current assets of $165.4 million were nearly twice current liabilities of $84.8 million, but accounts receivable represented $129.2 million of current assets while cash was only $15.4 million.
  • Statement classifications make margin analysis difficult: Several quarters report zero cost of revenue and unusually large “other operating expenses,” while Q4 2026 reports gross profit of $280.9 million on revenue of $164.3 million. These figures may reflect classification or presentation issues, so investors should rely more heavily on operating income and cash flow until the reporting pattern is clearer.
  • Q4 2026 profitability weakened: Net income fell approximately 34% sequentially from $13.3 million to $8.7 million, while diluted EPS declined from $0.89 to $0.59.
  • Capital returns and investment continue to consume cash: Q4 2026 included $4.2 million of share repurchases and $3.2 million of capital expenditures, while total financing activity reduced cash by $4.5 million. Continued buybacks could limit liquidity if operating cash flow softens.
10/15/26 05:30 PM ETAI Generated. May Contain Errors.

IBEX Financials - Frequently Asked Questions

According to the most recent income statement we have on file, IBEX's fiscal year ends in June. Their fiscal year 2026 ended on June 30, 2026.

IBEX's net income appears to be on an upward trend, with a most recent value of $46.33 million in 2026, compared with -$15.88 million in 2018. The previous period was $36.86 million in 2025. Check out IBEX's forecast to explore projected trends and price targets.

IBEX's total operating income in 2026 was $54.96 million, based on the following breakdown:
  • Total Gross Profit: $644.08 million
  • Total Operating Expenses: $589.11 million

Over the last 8 years, IBEX's total revenue changed from $342.20 million in 2018 to $644.08 million in 2026, a change of 88.2%.

In the past 10 quarters, IBEX's cash and equivalents has ranged from $12.98 million in Q3 2025 to $62.31 million in Q1 2025, and is currently $15.41 million as of their latest financial filing in Q3 2026.

IBEX had total debt of $1.66 million at the end of 2026, a 2.5% increase from 2025, and none in 2018.

Over the last 8 years, IBEX's book value per share changed from 0.00 in 2018 to 12.71 in 2026, a change of 1,271.4%.


Related Companies

Financial statements for NASDAQ:IBEX last updated on 9/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Trump's New Dollar
Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...
Porter & Company | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The end may be near for these iconic stocks
Marc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...
Chaikin Analytics | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel